Cargando…
Synthesis, Antiproliferative Effect and In Silico LogP Prediction of BIM-23052 Analogs Containing Tyr Instead of Phe
(1) Background: Hydrophobicity (or lipophilicity) is a limiting factor in the ability of molecules to pass through cell membranes and to perform their function. The ability to efficiently access cytosol is especially important when a synthetic compound has the potential to become a drug substance. D...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142861/ https://www.ncbi.nlm.nih.gov/pubmed/37111609 http://dx.doi.org/10.3390/pharmaceutics15041123 |
_version_ | 1785033713921294336 |
---|---|
author | Danalev, Dancho Iliev, Ivan Dobrev, Stefan Angelova, Silvia Petrin, Stoiko Dzimbova, Tatyana Ivanova, Elena Borisova, Dessislava Naydenova, Emilia |
author_facet | Danalev, Dancho Iliev, Ivan Dobrev, Stefan Angelova, Silvia Petrin, Stoiko Dzimbova, Tatyana Ivanova, Elena Borisova, Dessislava Naydenova, Emilia |
author_sort | Danalev, Dancho |
collection | PubMed |
description | (1) Background: Hydrophobicity (or lipophilicity) is a limiting factor in the ability of molecules to pass through cell membranes and to perform their function. The ability to efficiently access cytosol is especially important when a synthetic compound has the potential to become a drug substance. D-Phe-Phe-Phe-D-Trp-Lys-Thr-Phe-Thr-NH(2) (BIM-23052) is a linear analog of somatostatin with established in vitro GH-inhibitory activity in nanomolar (nm) concentrations and high affinity to different somatostatin receptors. (2) Methods: Series of analogs of BIM-23052 were synthesized where Phe residue(s) in the BIM-23052 molecule were replaced with Tyr using standard SPPS, Fmoc/t-Bu strategy. Analyses of target compounds were performed using HPLC/MS technique. Toxicity and antiproliferative activity were studied using in vitro NRU and MTT assays. The values of logP (partition coefficient in octanol/water) for BIM-23052 and its analogs were calculated. (3) Results: The obtained data show the best antiproliferative effect against studied cancer cells for compound D-Phe-Phe-Phe-D-Trp-Lys-Thr-Tyr(7)-Thr-NH(2) (DD8), the most lipophilic compound according to the predicted logP values. (4) Conclusions: Multiple analyses of the obtained data reveal that compound D-Phe-Phe-Phe-D-Trp-Lys-Thr-Tyr(7)-Thr-NH(2) (DD8) where one Phe is replaced by Tyr has the best combination of cytotoxicity, antiproliferative effect and hydrolytic stability. |
format | Online Article Text |
id | pubmed-10142861 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-101428612023-04-29 Synthesis, Antiproliferative Effect and In Silico LogP Prediction of BIM-23052 Analogs Containing Tyr Instead of Phe Danalev, Dancho Iliev, Ivan Dobrev, Stefan Angelova, Silvia Petrin, Stoiko Dzimbova, Tatyana Ivanova, Elena Borisova, Dessislava Naydenova, Emilia Pharmaceutics Article (1) Background: Hydrophobicity (or lipophilicity) is a limiting factor in the ability of molecules to pass through cell membranes and to perform their function. The ability to efficiently access cytosol is especially important when a synthetic compound has the potential to become a drug substance. D-Phe-Phe-Phe-D-Trp-Lys-Thr-Phe-Thr-NH(2) (BIM-23052) is a linear analog of somatostatin with established in vitro GH-inhibitory activity in nanomolar (nm) concentrations and high affinity to different somatostatin receptors. (2) Methods: Series of analogs of BIM-23052 were synthesized where Phe residue(s) in the BIM-23052 molecule were replaced with Tyr using standard SPPS, Fmoc/t-Bu strategy. Analyses of target compounds were performed using HPLC/MS technique. Toxicity and antiproliferative activity were studied using in vitro NRU and MTT assays. The values of logP (partition coefficient in octanol/water) for BIM-23052 and its analogs were calculated. (3) Results: The obtained data show the best antiproliferative effect against studied cancer cells for compound D-Phe-Phe-Phe-D-Trp-Lys-Thr-Tyr(7)-Thr-NH(2) (DD8), the most lipophilic compound according to the predicted logP values. (4) Conclusions: Multiple analyses of the obtained data reveal that compound D-Phe-Phe-Phe-D-Trp-Lys-Thr-Tyr(7)-Thr-NH(2) (DD8) where one Phe is replaced by Tyr has the best combination of cytotoxicity, antiproliferative effect and hydrolytic stability. MDPI 2023-03-31 /pmc/articles/PMC10142861/ /pubmed/37111609 http://dx.doi.org/10.3390/pharmaceutics15041123 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Danalev, Dancho Iliev, Ivan Dobrev, Stefan Angelova, Silvia Petrin, Stoiko Dzimbova, Tatyana Ivanova, Elena Borisova, Dessislava Naydenova, Emilia Synthesis, Antiproliferative Effect and In Silico LogP Prediction of BIM-23052 Analogs Containing Tyr Instead of Phe |
title | Synthesis, Antiproliferative Effect and In Silico LogP Prediction of BIM-23052 Analogs Containing Tyr Instead of Phe |
title_full | Synthesis, Antiproliferative Effect and In Silico LogP Prediction of BIM-23052 Analogs Containing Tyr Instead of Phe |
title_fullStr | Synthesis, Antiproliferative Effect and In Silico LogP Prediction of BIM-23052 Analogs Containing Tyr Instead of Phe |
title_full_unstemmed | Synthesis, Antiproliferative Effect and In Silico LogP Prediction of BIM-23052 Analogs Containing Tyr Instead of Phe |
title_short | Synthesis, Antiproliferative Effect and In Silico LogP Prediction of BIM-23052 Analogs Containing Tyr Instead of Phe |
title_sort | synthesis, antiproliferative effect and in silico logp prediction of bim-23052 analogs containing tyr instead of phe |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142861/ https://www.ncbi.nlm.nih.gov/pubmed/37111609 http://dx.doi.org/10.3390/pharmaceutics15041123 |
work_keys_str_mv | AT danalevdancho synthesisantiproliferativeeffectandinsilicologppredictionofbim23052analogscontainingtyrinsteadofphe AT ilievivan synthesisantiproliferativeeffectandinsilicologppredictionofbim23052analogscontainingtyrinsteadofphe AT dobrevstefan synthesisantiproliferativeeffectandinsilicologppredictionofbim23052analogscontainingtyrinsteadofphe AT angelovasilvia synthesisantiproliferativeeffectandinsilicologppredictionofbim23052analogscontainingtyrinsteadofphe AT petrinstoiko synthesisantiproliferativeeffectandinsilicologppredictionofbim23052analogscontainingtyrinsteadofphe AT dzimbovatatyana synthesisantiproliferativeeffectandinsilicologppredictionofbim23052analogscontainingtyrinsteadofphe AT ivanovaelena synthesisantiproliferativeeffectandinsilicologppredictionofbim23052analogscontainingtyrinsteadofphe AT borisovadessislava synthesisantiproliferativeeffectandinsilicologppredictionofbim23052analogscontainingtyrinsteadofphe AT naydenovaemilia synthesisantiproliferativeeffectandinsilicologppredictionofbim23052analogscontainingtyrinsteadofphe |